Background:
Human myeloproliferative disorders form a range of clonal haematological malignant diseases, the main members of which are polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis.
4/7/2008 From Bench to Bedside in One Year: Stem Cell Research Leads to Potential New Therapy for Rare Blood
Disorder A unique partnership between industry and academia has led to
human clinical trials of a new drug for a rare class of blood diseases called
myeloproliferative disorders (MPD), which are all driven by the same genetic mutation and can evolve into leuk... More...